Intra-Cellular Therapies Inc (ITCI) Rapporto sugli Utili - Previsioni e Surprise Ratio

Pubblicita'

Storico dei ricavi trimestrali

ITCI rapporto: 77%

100%

ITCI supera 27 di 35 ultime stime

Data del prossimo reportFeb 27, 2025

Stimato per Q4 24:$-0.05

Cambiamenti implicati per il Q3 24:-80.00%

Cambiamenti implicati per il Q4 23:-83.33%

Periodo Bilanci	Data Riportata	EPS / Previsioni	Sorpresa
Q3 24	Oct 30, 2024	$-0.25 / $-0.18	$-0.07 / -38.89%
Q2 24	Aug 7, 2024	$-0.16 / $-0.18	$0.02 / 11.11%
Q1 24	May 7, 2024	$-0.16 / $-0.31	$0.15 / 48.39%
Q4 23	Feb 22, 2024	$-0.3 / $-0.44	$0.14 / 31.82%
Q3 23	Nov 2, 2023	$-0.25 / $-0.59	$0.34 / 57.63%
Q2 23	Aug 3, 2023	$-0.45 / $-0.62	$0.17 / 27.42%
Q1 23	May 4, 2023	$-0.46 / $-0.63	$0.17 / 26.98%
Q4 22	Mar 1, 2023	$-0.45 / $-0.62	$0.17 / 27.42%

Fornitori di Dati: Xignite Logo